NO20022541L - Fast preparat - Google Patents

Fast preparat

Info

Publication number
NO20022541L
NO20022541L NO20022541A NO20022541A NO20022541L NO 20022541 L NO20022541 L NO 20022541L NO 20022541 A NO20022541 A NO 20022541A NO 20022541 A NO20022541 A NO 20022541A NO 20022541 L NO20022541 L NO 20022541L
Authority
NO
Norway
Prior art keywords
compound
solid preparation
crystal
weight distribution
distribution value
Prior art date
Application number
NO20022541A
Other languages
English (en)
Other versions
NO20022541D0 (no
Inventor
Motokazu Iwata
Teruaki Kuriyama
Megumi Fujita
Keiichi Fujiwara
Shiro Kato
Hiroshi Harada
Akihito Fujii
Osamu Odai
Hitoshi Kawashima
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/661,577 external-priority patent/US6458824B1/en
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of NO20022541D0 publication Critical patent/NO20022541D0/no
Publication of NO20022541L publication Critical patent/NO20022541L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Fast preparat omfattende et krystall av [3-[(2R)-[[(2R)-(3-klorfenyl)-2-hydroksyetyl]amino]propyl]-lH-indol-7-yloksy]-eddiksyre (Forbindelse A), spesielt et krystall av Forbindelse A som har en partikkelstørrelse på høyst 100 um ved en kumulativ vektfordelingsverdi på 50% og høyst 200 um ved en kumulativ vektfordelingsverdi på 95%, fortrinnsvis et fast preparat som har den utmerkede stabilitet og ensartethet av innholdet av Forbindelse A som oppnås ved fremstilling av granuler av krys-tallet av Forbindelse A med fyllstoffer, desintegreringsmidler og bindemidler og påfølgende blanding av disse granuler med eksterne eksipienser.
NO20022541A 1999-11-30 2002-05-29 Fast preparat NO20022541L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33954799 1999-11-30
US09/661,577 US6458824B1 (en) 1999-11-30 2000-09-14 Solid preparation
PCT/JP2000/008283 WO2001040182A2 (en) 1999-11-30 2000-11-24 Solid pharmaceutical preparation

Publications (2)

Publication Number Publication Date
NO20022541D0 NO20022541D0 (no) 2002-05-29
NO20022541L true NO20022541L (no) 2002-07-29

Family

ID=26576443

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022541A NO20022541L (no) 1999-11-30 2002-05-29 Fast preparat

Country Status (14)

Country Link
EP (1) EP1235801A2 (no)
JP (1) JP2003515587A (no)
CN (1) CN1433403A (no)
AU (1) AU1550501A (no)
CA (1) CA2391646A1 (no)
CZ (1) CZ20021833A3 (no)
HU (1) HUP0203865A3 (no)
IL (1) IL149635A0 (no)
MX (1) MXPA02005326A (no)
NO (1) NO20022541L (no)
NZ (1) NZ519086A (no)
PL (1) PL356468A1 (no)
SK (1) SK7362002A3 (no)
WO (1) WO2001040182A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050010512A (ko) * 2002-06-12 2005-01-27 스미또모 세이야꾸 가부시키가이샤 인돌, 인다졸 및 벤즈아졸류
JP3759949B2 (ja) * 2002-12-17 2006-03-29 湧永製薬株式会社 遮光剤及び皮膜組成物
DK3023095T3 (en) * 2004-01-20 2018-08-20 Novartis Ag Directly pressed wording and approach

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281865B6 (sk) * 1994-11-29 2001-08-06 Dainippon Pharmaceutical Co., Ltd. Indolový derivát a jeho optický izomér, spôsob jeho prípravy a farmaceutický prostriedok
JPH11255743A (ja) * 1998-03-06 1999-09-21 Dainippon Pharmaceut Co Ltd 光学活性のインドール誘導体の製造方法及びその製造中間体

Also Published As

Publication number Publication date
PL356468A1 (en) 2004-06-28
AU1550501A (en) 2001-06-12
WO2001040182A3 (en) 2002-06-27
CZ20021833A3 (cs) 2003-02-12
IL149635A0 (en) 2002-11-10
EP1235801A2 (en) 2002-09-04
HUP0203865A2 (hu) 2003-03-28
WO2001040182A2 (en) 2001-06-07
NO20022541D0 (no) 2002-05-29
MXPA02005326A (es) 2003-02-12
CA2391646A1 (en) 2001-06-07
HUP0203865A3 (en) 2004-05-28
JP2003515587A (ja) 2003-05-07
CN1433403A (zh) 2003-07-30
NZ519086A (en) 2003-11-28
SK7362002A3 (en) 2003-02-04

Similar Documents

Publication Publication Date Title
BR0016882A (pt) ésteres derivados de (rr,ss)-3-(2-dimetilaminometil-1-hidroxicicloexil)fenil 2-hidroxibenzoato
CA2317106A1 (en) Method and composition of an oral preparation of itraconazole
WO2002058698A8 (en) Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
WO2002058690A3 (en) Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
HUP0400382A2 (hu) Késleltetett leadású készítmény és eljárás annak előállítására
CA2367020A1 (en) Method for producing solid dosage forms containing cyclodextrin
ES2186577A1 (es) Polipropileno de metaloceno estabilizado.
WO2002064136A3 (en) Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
CA2336412A1 (en) Medicament for treatment of diabetes
MY135954A (en) Crystalline form of (s)-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
MY125099A (en) Comminuted form of (s)-2-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) penyl] propanoic acid
MXPA03007887A (es) Metodo para obtener microparticulas que contienen inhibidor de h(+), k(+)-atp-asa.
EP1256338A3 (en) A process for the preparation of direct tabletting formulations and aids
NO20022541L (no) Fast preparat
AU8336898A (en) Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
WO1997031016A3 (en) New inhibitors of sh2-mediated processes
NO20004919L (no) Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
WO2000046210A3 (en) New process for preparing pesticidal intermediates
WO2002096855A3 (en) Anticholinergic compounds and methods of use
BR9908970A (pt) Processo para a preparação do composto, e, composto
BR0008586A (pt) Processo de preparação de aminoácidos quirais e processo de preparação de compostos a partir destes
AU2001295837A1 (en) Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
ES2166937T3 (es) Metodo para preparar n2-arilsulfonil-l-argininamidas.
WO2002011668A3 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
BR0015913A (pt) Preparação sólida

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application